Skip to main content
. 2022 May 17;13:872470. doi: 10.3389/fimmu.2022.872470

Figure 3.

Figure 3

EGFR/MAP2K1/mTOR/TEAD1/YAP1 mediate lung cancer-specific activation of onco-functional molecules and therapeutic responses. (A) Direct protein-protein interaction (PPI) network, (B) lung cancer-specific context-induced PP1 network, and (C) associated survival genes of EGFR/MAP2K1/mTOR/TEAD1/YAP1 in lung cancer. (D) Heatmap of EGFR/MAP2K1/mTOR/TEAD1/YAP1-induced therapeutic resistance.